Ricciardi Natale SDirectorOption exercise · Feb 27, 2026
About RAPID MICRO BIOSYSTEMS, INC. (RPID): stock profile, AI score and financials
RAPID MICRO BIOSYSTEMS, INC. (RPID) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RPID at 27.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,548 of 2,925 stocks — the bottom half of the AI-ranked universe. RPID scores in the top quartile across institutional flow (91.7), revenue growth (79.7). Areas of concern include balance sheet strength (1.8) and profitability (6.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), RAPID MICRO BIOSYSTEMS, INC. reports quarterly revenue of $8.1M, net income of $-12.9M, an operating margin of -153.0%. Top institutional holders of RPID by reported 13-F value include Bain Capital Life Sciences Investors, ARMISTICE CAPITAL, ABG-WTT Global Life Science Capital Partners GP Ltd, based on the most recent SEC filings. RPID trades on the Nasdaq exchange and files with the SEC under CIK 1380106. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RPID daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RAPID MICRO BIOSYSTEMS, INC. directly from SEC EDGAR.